HomeInsightsEPS

Sun Pharmaceuticals Industries Ltd EPS

Sun Pharmaceuticals Industries Ltd EPS

stocks purchased

₹ 0.3 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

1.6 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 22, 2024

Image

Sun Pharmaceuticals Industries Ltd

NSE: SUNPHARMA

EPS

₹ 46.72

Last updated on: Nov 21, 2024

Key Highlights

  • The Earning per Share of Sun Pharmaceuticals Industries Ltd is ₹ 46.72 as of 21 Nov 24 .
  • The earning per share of Sun Pharmaceuticals Industries Ltd changed from ₹ 8.6 to ₹ 12.7 over 10 quarters. This represents a CAGR of 16.88% .

Historical Earning per Share of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in

Company Fundamentals for Sun Pharmaceuticals Industries Ltd

Market Cap

426,517 Cr

EPS

46.7

P/E Ratio (TTM) *

38.0

P/B Ratio (TTM) *

6.2

Day’s High *

1789.5

Day’s Low

1771.85

DTE *

0.0

ROE *

16.0

52 Week High

1960.2

52 Week Low

1185.25

ROCE *

18.1

Market Price of Sun Pharmaceuticals Industries Ltd

1M

1Y

3Y

5Y

Monitoring Sun Pharmaceuticals Industries Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Nov 20241777.65
19 Nov 20241775.2
18 Nov 20241747.2
14 Nov 20241768.6
13 Nov 20241779.3
12 Nov 20241799.85
11 Nov 20241794.9
08 Nov 20241811.35
07 Nov 20241791.5
06 Nov 20241827.25

SWOT Analysis Of Sun Pharmaceuticals Industries Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Sun Pharmaceuticals Industries Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Sun Pharmaceuticals Industries Ltd

Market Value

4,26,518

Asset Value

40,926

9.4 X

Value addition

* All values are in Rupees

Competitive Comparison of EPS

Company NameEPSMarket Cap (INR Cr.)
Sun Pharmaceuticals Industries Ltd464,26,517
Divis Laboratories Ltd691,58,636
Cipla Ltd571,18,365
Torrent Pharmaceuticals Ltd511,05,067
Mankind Pharma Ltd521,02,273
Dr Reddys Laboratories Ltd6399,671

Historical Market Cap of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in crore

Historical Revenue of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in crore

Historical EBITDA of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in crore

Historical Net Profit of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Sun Pharmaceuticals Industries Ltd News Hub

News

Sun Pharma tumbles after US court halts Leqselvi launch

Aa result of the court's decision, Sun Pharma has been temporarily barred from launching L...

Read more

04 Nov 202411:14

News

Sun Pharmaceuticals Industries Ltd up for third straight session

Sun Pharmaceuticals Industries Ltd is up for a third straight session today. The stock is ...

Read more

28 Oct 202413:05

News

Sun Pharma gains after Q2 PAT climbs 28% YoY to Rs 3,040 cr

Profit before tax was at Rs 3,597.88 crore in Q2 FY25, registering a growth of 28.91% on Y...

Read more

28 Oct 202416:01

News

Sun Pharmaceuticals Industries to hold board meeting

Sun Pharmaceuticals Industries will hold a meeting of the Board of Directors of the Compan...

Read more

09 Oct 202417:30

News

Sun Pharma inks global licensing agreement with Philogen

Sun Pharmaceutical Industries and Philogen S.p.A (Philogen) today announced that they have...

Read more

01 Oct 202410:34

News

Sun Pharma inks exclusive pact with Philogen for commercializing anti-cancer drug Fibromun

Philogen is an Italian-Swiss company active in the biotechnology sector, specialized in th...

Read more

01 Oct 202410:34

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

July 2024

PPT

May 2024

Transcript

Mar 2024

PPT

Feb 2024

Transcript

Jan 2024

PPT

Nov 2023

Transcript

Sep 2023

PPT

May 2023

Transcript

Apr 2023

PPT

Nov 2022

Transcript

Sep 2022

PPT

Aug 2022

Transcript

June 2022

Transcript

Mar 2022

PPT

Feb 2022

Transcript

Nov 2021

Transcript

Aug 2021

Transcript

June 2021

Transcript

Jan 2021

Transcript

Oct 2020

Transcript

FAQs for EPS of Sun Pharmaceuticals Industries Ltd

What is the EPS of Sun Pharmaceuticals Industries Ltd stock?

The Earnings Per Share (EPS) of Sun Pharmaceuticals Industries Ltd is 46.72. An EPS is the amount of net income attributed to each share of a common stock.

How is Sun Pharmaceuticals Industries Ltd EPS calculated?

The EPS of Sun Pharmaceuticals Industries Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Sun Pharmaceuticals Industries Ltd report its EPS?

Sun Pharmaceuticals Industries Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Sun Pharmaceuticals Industries Ltd EPS?

Factors that influence the EPS of Sun Pharmaceuticals Industries Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Sun Pharmaceuticals Industries Ltd EPS growth indicate future performance?

Yes, consistent growth in Sun Pharmaceuticals Industries Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*